γδ-Enriched CAR-T Cell Therapy for Bone Metastatic Castrate-Resistant Prostate Cancer

0
162
Scientists reported a combinatorial strategy to treat bone metastatic castrate-resistant prostate cancer using γδ-enriched chimeric antigen receptor (CAR) T cells and zoledronate.
[Science Advances]
Full ArticlePress Release